

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 3.96281970 |
| 2 | barbed-end actin filament capping (GO:0051016) | 3.93274075 |
| 3 | positive regulation of receptor recycling (GO:0001921) | 3.86348408 |
| 4 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.83011733 |
| 5 | apoptotic cell clearance (GO:0043277) | 3.63967975 |
| 6 | adenosine receptor signaling pathway (GO:0001973) | 3.51545521 |
| 7 | protein localization to endosome (GO:0036010) | 3.51125171 |
| 8 | stress fiber assembly (GO:0043149) | 3.48314033 |
| 9 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.32462141 |
| 10 | regulation of early endosome to late endosome transport (GO:2000641) | 3.29732279 |
| 11 | low-density lipoprotein particle clearance (GO:0034383) | 3.27091941 |
| 12 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.14984176 |
| 13 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.14485793 |
| 14 | macroautophagy (GO:0016236) | 3.11107913 |
| 15 | angiogenesis involved in wound healing (GO:0060055) | 3.10283262 |
| 16 | positive regulation of protein dephosphorylation (GO:0035307) | 3.09549772 |
| 17 | synaptonemal complex assembly (GO:0007130) | 3.03533338 |
| 18 | platelet aggregation (GO:0070527) | 3.00253870 |
| 19 | regulation of hippo signaling (GO:0035330) | 2.99588130 |
| 20 | negative regulation of focal adhesion assembly (GO:0051895) | 2.98638098 |
| 21 | negative regulation of cell junction assembly (GO:1901889) | 2.98638098 |
| 22 | negative regulation of adherens junction organization (GO:1903392) | 2.98638098 |
| 23 | basement membrane organization (GO:0071711) | 2.93739135 |
| 24 | plasma membrane repair (GO:0001778) | 2.91509612 |
| 25 | skin morphogenesis (GO:0043589) | 2.90092531 |
| 26 | cell-substrate junction assembly (GO:0007044) | 2.89955043 |
| 27 | synaptonemal complex organization (GO:0070193) | 2.89338800 |
| 28 | cell-cell junction maintenance (GO:0045217) | 2.85735177 |
| 29 | sodium ion export (GO:0071436) | 2.85374894 |
| 30 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.84290235 |
| 31 | epithelial cell-cell adhesion (GO:0090136) | 2.84256855 |
| 32 | desmosome organization (GO:0002934) | 2.80659709 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 2.79652225 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 2.79652225 |
| 35 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.78517730 |
| 36 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.78197254 |
| 37 | regulation of p38MAPK cascade (GO:1900744) | 2.77136681 |
| 38 | protein heterotrimerization (GO:0070208) | 2.75960207 |
| 39 | glomerular basement membrane development (GO:0032836) | 2.75499923 |
| 40 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.74915447 |
| 41 | atrioventricular valve morphogenesis (GO:0003181) | 2.74804601 |
| 42 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74790172 |
| 43 | negative regulation of fatty acid transport (GO:2000192) | 2.73693987 |
| 44 | protein retention in ER lumen (GO:0006621) | 2.72564135 |
| 45 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.71974901 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 2.70966376 |
| 47 | extracellular fibril organization (GO:0043206) | 2.69714138 |
| 48 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.67973791 |
| 49 | cell adhesion mediated by integrin (GO:0033627) | 2.66459319 |
| 50 | piRNA metabolic process (GO:0034587) | 2.66215068 |
| 51 | ovulation cycle (GO:0042698) | 2.65634803 |
| 52 | endocytic recycling (GO:0032456) | 2.64473312 |
| 53 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.64266697 |
| 54 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63229646 |
| 55 | positive regulation of male gonad development (GO:2000020) | 2.63135655 |
| 56 | endothelial cell chemotaxis (GO:0035767) | 2.62968493 |
| 57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61068568 |
| 58 | ectoderm development (GO:0007398) | 2.60655776 |
| 59 | mannose metabolic process (GO:0006013) | 2.58657492 |
| 60 | regulation of tight junction assembly (GO:2000810) | 2.57782224 |
| 61 | response to magnesium ion (GO:0032026) | 2.56404647 |
| 62 | positive regulation of osteoblast proliferation (GO:0033690) | 2.55601311 |
| 63 | cell volume homeostasis (GO:0006884) | 2.54773981 |
| 64 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.54409583 |
| 65 | adherens junction assembly (GO:0034333) | 2.52511505 |
| 66 | Rho protein signal transduction (GO:0007266) | 2.49910595 |
| 67 | fibril organization (GO:0097435) | 2.49523407 |
| 68 | cellular response to interferon-alpha (GO:0035457) | 2.48648026 |
| 69 | protein targeting to plasma membrane (GO:0072661) | 2.48063528 |
| 70 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.47720476 |
| 71 | glutamate secretion (GO:0014047) | 2.47547572 |
| 72 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.46868658 |
| 73 | establishment of apical/basal cell polarity (GO:0035089) | 2.46444731 |
| 74 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.46404758 |
| 75 | actin filament bundle assembly (GO:0051017) | 2.44458620 |
| 76 | actin filament bundle organization (GO:0061572) | 2.44458620 |
| 77 | signal complex assembly (GO:0007172) | 2.42901001 |
| 78 | apoptotic process involved in morphogenesis (GO:0060561) | 2.42845897 |
| 79 | plasma membrane fusion (GO:0045026) | 2.42667342 |
| 80 | platelet degranulation (GO:0002576) | 2.41404296 |
| 81 | negative regulation of catenin import into nucleus (GO:0035414) | 2.41041545 |
| 82 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.39960020 |
| 83 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.38624333 |
| 84 | sex determination (GO:0007530) | 2.37885930 |
| 85 | endodermal cell differentiation (GO:0035987) | 2.37803037 |
| 86 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.37748074 |
| 87 | regulation of cholesterol storage (GO:0010885) | 2.35718761 |
| 88 | growth hormone secretion (GO:0030252) | 2.35030617 |
| 89 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.33997064 |
| 90 | activation of protein kinase A activity (GO:0034199) | 2.33612642 |
| 91 | positive regulation of p38MAPK cascade (GO:1900745) | 2.32132862 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 2.32126472 |
| 93 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.31920737 |
| 94 | axon extension involved in axon guidance (GO:0048846) | 2.31920737 |
| 95 | regulation of protein dephosphorylation (GO:0035304) | 2.31699601 |
| 96 | anatomical structure regression (GO:0060033) | 2.30910517 |
| 97 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.30511034 |
| 98 | hippo signaling (GO:0035329) | 2.30342953 |
| 99 | adhesion of symbiont to host (GO:0044406) | 2.29487809 |
| 100 | regulation of male gonad development (GO:2000018) | 2.29233312 |
| 101 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28728288 |
| 102 | cortical actin cytoskeleton organization (GO:0030866) | 2.28536835 |
| 103 | wound healing, spreading of epidermal cells (GO:0035313) | 2.27732463 |
| 104 | positive regulation of axon extension (GO:0045773) | 2.27232729 |
| 105 | establishment of protein localization to plasma membrane (GO:0090002) | 2.27025828 |
| 106 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.26365021 |
| 107 | peptidyl-proline hydroxylation (GO:0019511) | 2.26171641 |
| 108 | actin filament capping (GO:0051693) | 2.25907706 |
| 109 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.24461364 |
| 110 | regulation of ARF GTPase activity (GO:0032312) | 2.22979875 |
| 111 | modulation by symbiont of host cellular process (GO:0044068) | 2.22940683 |
| 112 | modulation by virus of host morphology or physiology (GO:0019048) | 2.22591279 |
| 113 | cerebellar granule cell differentiation (GO:0021707) | 2.22529238 |
| 114 | hyaluronan catabolic process (GO:0030214) | 2.21895615 |
| 115 | fibroblast migration (GO:0010761) | 2.21875675 |
| 116 | regulation of water loss via skin (GO:0033561) | 2.21849715 |
| 117 | regulation of receptor recycling (GO:0001919) | 2.21822916 |
| 118 | decidualization (GO:0046697) | 2.21751874 |
| 119 | myelin maintenance (GO:0043217) | 2.21353488 |
| 120 | protein maturation by protein folding (GO:0022417) | 2.21322033 |
| 121 | vesicle targeting (GO:0006903) | 2.20950944 |
| 122 | glial cell proliferation (GO:0014009) | 2.20722400 |
| 123 | polarized epithelial cell differentiation (GO:0030859) | 2.20409704 |
| 124 | extracellular matrix assembly (GO:0085029) | 2.19961268 |
| 125 | regulation of leukocyte degranulation (GO:0043300) | 2.19777486 |
| 126 | regulation of platelet aggregation (GO:0090330) | 2.19655984 |
| 127 | regulation of ARF protein signal transduction (GO:0032012) | 2.19230997 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.18150199 |
| 129 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.17424812 |
| 130 | establishment of monopolar cell polarity (GO:0061162) | 2.17424812 |
| 131 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.17056585 |
| 132 | activation of JUN kinase activity (GO:0007257) | 2.17045969 |
| 133 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.17040376 |
| 134 | negative regulation of cell size (GO:0045792) | 2.16834525 |
| 135 | response to acidic pH (GO:0010447) | 2.16148495 |
| 136 | positive regulation of vesicle fusion (GO:0031340) | 2.15972940 |
| 137 | focal adhesion assembly (GO:0048041) | 2.15501598 |
| 138 | cell-substrate adherens junction assembly (GO:0007045) | 2.15501598 |
| 139 | labyrinthine layer blood vessel development (GO:0060716) | 2.15078732 |
| 140 | positive regulation of fibroblast migration (GO:0010763) | 2.14117919 |
| 141 | synaptic vesicle exocytosis (GO:0016079) | 2.13797485 |
| 142 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.11470488 |
| 143 | regulation of glomerular filtration (GO:0003093) | 2.10641683 |
| 144 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.10471669 |
| 145 | regulation of integrin activation (GO:0033623) | 2.10135601 |
| 146 | activation of Rac GTPase activity (GO:0032863) | 2.08814365 |
| 147 | gonadal mesoderm development (GO:0007506) | 2.07557851 |
| 148 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.07060939 |
| 149 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.05331245 |
| 150 | extracellular matrix disassembly (GO:0022617) | 2.05198973 |
| 151 | hypotonic response (GO:0006971) | 2.03925988 |
| 152 | semaphorin-plexin signaling pathway (GO:0071526) | 2.02611493 |
| 153 | membrane budding (GO:0006900) | 2.01413754 |
| 154 | response to laminar fluid shear stress (GO:0034616) | 2.01402844 |
| 155 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.00966713 |
| 156 | regulation of meiosis I (GO:0060631) | 1.98853738 |
| 157 | substrate adhesion-dependent cell spreading (GO:0034446) | 1.98022250 |
| 158 | renal system process involved in regulation of blood volume (GO:0001977) | 1.97957937 |
| 159 | regulation of transforming growth factor beta1 production (GO:0032908) | 1.97830129 |
| 160 | collagen fibril organization (GO:0030199) | 1.97733885 |
| 161 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.97562919 |
| 162 | lymphangiogenesis (GO:0001946) | 1.97508322 |
| 163 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.97483657 |
| 164 | endothelial cell morphogenesis (GO:0001886) | 1.97394024 |
| 165 | protein insertion into membrane (GO:0051205) | 1.97144651 |
| 166 | negative regulation of organic acid transport (GO:0032891) | 1.96964696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.90994547 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.11214901 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.93992984 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.62382964 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58613069 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.36538565 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08107225 |
| 8 | KDM2B_26808549_Chip-Seq_K562_Human | 2.04561915 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91920135 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91671433 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89753577 |
| 12 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.86861000 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.86552210 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86220968 |
| 15 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.84413136 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79226648 |
| 17 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.78467842 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74760244 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71682455 |
| 20 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.67696713 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60432527 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.57452220 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56791792 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55153115 |
| 25 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51496343 |
| 26 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.50874553 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50643445 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50538599 |
| 29 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.49975754 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42188693 |
| 31 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.40029741 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39915441 |
| 33 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39725835 |
| 34 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38112325 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34574809 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.34394395 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34200552 |
| 38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34063795 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33824517 |
| 40 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33000758 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32546492 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31251993 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.30128674 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.30128674 |
| 45 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29867665 |
| 46 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27891869 |
| 47 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27052031 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26808531 |
| 49 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26604150 |
| 50 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25523896 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25074871 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24994732 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24600321 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23385213 |
| 55 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22665807 |
| 56 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22153735 |
| 57 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21735559 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21600508 |
| 59 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21497573 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21404751 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21343896 |
| 62 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20694710 |
| 63 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19756261 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18889891 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18604896 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17616285 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17195005 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15072587 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14643429 |
| 70 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.14229577 |
| 71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.14229577 |
| 72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.14229577 |
| 73 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12176961 |
| 74 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10792470 |
| 75 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.10769902 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10580246 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10449832 |
| 78 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.09773800 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.09707704 |
| 80 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.09435727 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08266792 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08153432 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08143157 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07570084 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07522735 |
| 86 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05765257 |
| 87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05679473 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05510221 |
| 89 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05193501 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04642934 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04604616 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04101552 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03899377 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03689916 |
| 95 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03568858 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03187951 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02781417 |
| 98 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02315922 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02225270 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01763530 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01600526 |
| 102 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01596427 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01489431 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01094761 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00139053 |
| 106 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99939610 |
| 107 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.99274989 |
| 108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99232049 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98923271 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98862509 |
| 111 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98687961 |
| 112 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97917923 |
| 113 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97883795 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96837694 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96629726 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96257548 |
| 117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95614304 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95332457 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95205563 |
| 120 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95194371 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95180769 |
| 122 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94913428 |
| 123 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94866256 |
| 124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94223650 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93426348 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92964388 |
| 127 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91603791 |
| 128 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90223039 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90103238 |
| 130 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90080816 |
| 131 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89876179 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89876179 |
| 133 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89855932 |
| 134 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89582124 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88169417 |
| 136 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87200607 |
| 137 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.86503419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 5.08439302 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.25391962 |
| 3 | MP0004858_abnormal_nervous_system | 3.18119472 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 3.03169135 |
| 5 | MP0003878_abnormal_ear_physiology | 3.03169135 |
| 6 | MP0005275_abnormal_skin_tensile | 3.02794232 |
| 7 | MP0005623_abnormal_meninges_morphology | 2.93075323 |
| 8 | MP0004272_abnormal_basement_membrane | 2.76015075 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.75919979 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.74266191 |
| 11 | MP0002796_impaired_skin_barrier | 2.54112488 |
| 12 | MP0005409_darkened_coat_color | 2.44844306 |
| 13 | MP0002254_reproductive_system_inflammat | 2.33031745 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.28964241 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.13735869 |
| 16 | MP0008260_abnormal_autophagy | 2.10966589 |
| 17 | MP0005076_abnormal_cell_differentiation | 2.00628311 |
| 18 | MP0003172_abnormal_lysosome_physiology | 1.98586783 |
| 19 | MP0001958_emphysema | 1.95607028 |
| 20 | MP0003283_abnormal_digestive_organ | 1.93984672 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.88016364 |
| 22 | MP0003879_abnormal_hair_cell | 1.81852578 |
| 23 | MP0005410_abnormal_fertilization | 1.80534721 |
| 24 | MP0003091_abnormal_cell_migration | 1.74019919 |
| 25 | MP0003045_fibrosis | 1.68260556 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.64928496 |
| 27 | MP0008995_early_reproductive_senescence | 1.58827603 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.52499208 |
| 29 | MP0005451_abnormal_body_composition | 1.50697405 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.48063613 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.44114753 |
| 32 | MP0002060_abnormal_skin_morphology | 1.42338498 |
| 33 | MP0000343_altered_response_to | 1.42040873 |
| 34 | MP0002295_abnormal_pulmonary_circulatio | 1.40383505 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.35320291 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.33877142 |
| 37 | MP0001849_ear_inflammation | 1.33862740 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.33675696 |
| 39 | MP0000751_myopathy | 1.33607372 |
| 40 | MP0009840_abnormal_foam_cell | 1.33302586 |
| 41 | MP0000858_altered_metastatic_potential | 1.31997803 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.31807057 |
| 43 | MP0000534_abnormal_ureter_morphology | 1.30916055 |
| 44 | MP0002896_abnormal_bone_mineralization | 1.30177243 |
| 45 | MP0000467_abnormal_esophagus_morphology | 1.28401036 |
| 46 | MP0005023_abnormal_wound_healing | 1.27291285 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.26958115 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.25548459 |
| 49 | MP0005501_abnormal_skin_physiology | 1.22088835 |
| 50 | MP0005375_adipose_tissue_phenotype | 1.19889401 |
| 51 | MP0004885_abnormal_endolymph | 1.19774309 |
| 52 | MP0003329_amyloid_beta_deposits | 1.19691072 |
| 53 | MP0005595_abnormal_vascular_smooth | 1.18743080 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.18004787 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.17709803 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.16928166 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.16888122 |
| 58 | MP0005670_abnormal_white_adipose | 1.15863350 |
| 59 | MP0010030_abnormal_orbit_morphology | 1.15698791 |
| 60 | MP0003279_aneurysm | 1.13449059 |
| 61 | MP0003941_abnormal_skin_development | 1.12504930 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.11842080 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.11718353 |
| 64 | MP0005165_increased_susceptibility_to | 1.11006804 |
| 65 | MP0003436_decreased_susceptibility_to | 1.10001813 |
| 66 | MP0003828_pulmonary_edema | 1.08716319 |
| 67 | MP0008874_decreased_physiological_sensi | 1.08072847 |
| 68 | MP0000537_abnormal_urethra_morphology | 1.07702791 |
| 69 | MP0004510_myositis | 1.06179645 |
| 70 | MP0000750_abnormal_muscle_regeneration | 1.05091299 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.03609824 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.02632932 |
| 73 | MP0010771_integument_phenotype | 1.00129047 |
| 74 | MP0009053_abnormal_anal_canal | 0.99053396 |
| 75 | MP0003385_abnormal_body_wall | 0.98071349 |
| 76 | MP0003075_altered_response_to | 0.97769253 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.96133280 |
| 78 | MP0000920_abnormal_myelination | 0.95900463 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.95487382 |
| 80 | MP0005166_decreased_susceptibility_to | 0.93243778 |
| 81 | MP0000249_abnormal_blood_vessel | 0.92220714 |
| 82 | MP0003115_abnormal_respiratory_system | 0.91809638 |
| 83 | MP0003942_abnormal_urinary_system | 0.91575670 |
| 84 | MP0003303_peritoneal_inflammation | 0.91094401 |
| 85 | MP0002168_other_aberrant_phenotype | 0.90886084 |
| 86 | MP0006138_congestive_heart_failure | 0.90213215 |
| 87 | MP0001440_abnormal_grooming_behavior | 0.90199182 |
| 88 | MP0004947_skin_inflammation | 0.89536169 |
| 89 | MP0000733_abnormal_muscle_development | 0.88261958 |
| 90 | MP0005083_abnormal_biliary_tract | 0.86610339 |
| 91 | MP0005390_skeleton_phenotype | 0.86297278 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.85761425 |
| 93 | MP0003448_altered_tumor_morphology | 0.85031917 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.84288270 |
| 95 | MP0004233_abnormal_muscle_weight | 0.83978879 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.83629056 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.83397900 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.83153400 |
| 99 | MP0000747_muscle_weakness | 0.81076794 |
| 100 | MP0002282_abnormal_trachea_morphology | 0.78639388 |
| 101 | MP0004270_analgesia | 0.78236954 |
| 102 | MP0001542_abnormal_bone_strength | 0.77537609 |
| 103 | MP0005503_abnormal_tendon_morphology | 0.76651257 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.76203912 |
| 105 | MP0003119_abnormal_digestive_system | 0.74933577 |
| 106 | MP0008569_lethality_at_weaning | 0.74243397 |
| 107 | MP0004130_abnormal_muscle_cell | 0.74163662 |
| 108 | MP0005621_abnormal_cell_physiology | 0.71857340 |
| 109 | MP0000604_amyloidosis | 0.71853784 |
| 110 | MP0003795_abnormal_bone_structure | 0.70862762 |
| 111 | MP0003690_abnormal_glial_cell | 0.67981312 |
| 112 | MP0003195_calcinosis | 0.66267369 |
| 113 | MP0009278_abnormal_bone_marrow | 0.66005523 |
| 114 | MP0005164_abnormal_response_to | 0.65823827 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.65334244 |
| 116 | MP0003635_abnormal_synaptic_transmissio | 0.64685024 |
| 117 | MP0001851_eye_inflammation | 0.64210590 |
| 118 | MP0004381_abnormal_hair_follicle | 0.63496788 |
| 119 | MP0004087_abnormal_muscle_fiber | 0.62952033 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.62546063 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.62345339 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.62339094 |
| 123 | MP0008004_abnormal_stomach_pH | 0.61452803 |
| 124 | MP0005367_renal/urinary_system_phenotyp | 0.60341573 |
| 125 | MP0000516_abnormal_urinary_system | 0.60341573 |
| 126 | MP0009931_abnormal_skin_appearance | 0.59103998 |
| 127 | MP0010678_abnormal_skin_adnexa | 0.58757778 |
| 128 | MP0001243_abnormal_dermal_layer | 0.57975727 |
| 129 | MP0000579_abnormal_nail_morphology | 0.57593218 |
| 130 | MP0000428_abnormal_craniofacial_morphol | 0.57414754 |
| 131 | MP0003634_abnormal_glial_cell | 0.57396380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Upper limb amyotrophy (HP:0009129) | 4.19887405 |
| 2 | Distal upper limb amyotrophy (HP:0007149) | 4.19887405 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.07177006 |
| 4 | Hand muscle atrophy (HP:0009130) | 3.93631233 |
| 5 | Increased mean platelet volume (HP:0011877) | 3.78114964 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.74237675 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.71711341 |
| 8 | Menorrhagia (HP:0000132) | 3.61791915 |
| 9 | Abnormal platelet volume (HP:0011876) | 3.57712801 |
| 10 | Obstructive sleep apnea (HP:0002870) | 3.47577261 |
| 11 | Purpura (HP:0000979) | 3.39609450 |
| 12 | Prolonged bleeding time (HP:0003010) | 3.32187089 |
| 13 | Atrophic scars (HP:0001075) | 3.28228316 |
| 14 | Male infertility (HP:0003251) | 3.18920614 |
| 15 | Difficulty climbing stairs (HP:0003551) | 3.07663108 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.02141990 |
| 17 | Ankle contracture (HP:0006466) | 3.00582255 |
| 18 | Shallow orbits (HP:0000586) | 3.00210950 |
| 19 | Petechiae (HP:0000967) | 2.94945571 |
| 20 | Fragile skin (HP:0001030) | 2.88780960 |
| 21 | Increased connective tissue (HP:0009025) | 2.81607097 |
| 22 | Broad face (HP:0000283) | 2.78394151 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.76898697 |
| 24 | Achilles tendon contracture (HP:0001771) | 2.70772370 |
| 25 | Dysostosis multiplex (HP:0000943) | 2.65429690 |
| 26 | Neurofibrillary tangles (HP:0002185) | 2.62184462 |
| 27 | Myokymia (HP:0002411) | 2.60484226 |
| 28 | Right ventricular cardiomyopathy (HP:0011663) | 2.58586650 |
| 29 | Bladder diverticulum (HP:0000015) | 2.53237663 |
| 30 | Cervical subluxation (HP:0003308) | 2.52684812 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.50996267 |
| 32 | Hypercortisolism (HP:0001578) | 2.50333514 |
| 33 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.49784247 |
| 34 | Polycythemia (HP:0001901) | 2.49634293 |
| 35 | Milia (HP:0001056) | 2.49096956 |
| 36 | Abnormality of the lower motor neuron (HP:0002366) | 2.45886466 |
| 37 | Facial diplegia (HP:0001349) | 2.43785398 |
| 38 | Alopecia of scalp (HP:0002293) | 2.40151947 |
| 39 | Hyporeflexia of lower limbs (HP:0002600) | 2.39681227 |
| 40 | Mitral valve prolapse (HP:0001634) | 2.36289072 |
| 41 | Epistaxis (HP:0000421) | 2.34840107 |
| 42 | Bronchomalacia (HP:0002780) | 2.34766073 |
| 43 | Peritonitis (HP:0002586) | 2.34522246 |
| 44 | Dilatation of the ascending aorta (HP:0005111) | 2.33505920 |
| 45 | Fragile nails (HP:0001808) | 2.31990808 |
| 46 | Hypoventilation (HP:0002791) | 2.31756929 |
| 47 | Thin bony cortex (HP:0002753) | 2.31344490 |
| 48 | Turricephaly (HP:0000262) | 2.27618686 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.25960785 |
| 50 | Aortic dissection (HP:0002647) | 2.22579204 |
| 51 | Short nail (HP:0001799) | 2.21388094 |
| 52 | Genu recurvatum (HP:0002816) | 2.19468344 |
| 53 | Nuclear cataract (HP:0100018) | 2.19042107 |
| 54 | Ankle clonus (HP:0011448) | 2.18496208 |
| 55 | Hyperparathyroidism (HP:0000843) | 2.15835648 |
| 56 | Mitral regurgitation (HP:0001653) | 2.13159387 |
| 57 | Impaired platelet aggregation (HP:0003540) | 2.13001942 |
| 58 | Abnormal platelet function (HP:0011869) | 2.13001942 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12879367 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12879367 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12879367 |
| 62 | Spinal rigidity (HP:0003306) | 2.11770597 |
| 63 | Diaphragmatic weakness (HP:0009113) | 2.11254495 |
| 64 | Blue sclerae (HP:0000592) | 2.10951299 |
| 65 | J-shaped sella turcica (HP:0002680) | 2.10296684 |
| 66 | Rectal prolapse (HP:0002035) | 2.09343135 |
| 67 | Aneurysm (HP:0002617) | 2.09151731 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07043710 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07043710 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07043710 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06112062 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.06112062 |
| 73 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.03863651 |
| 74 | Aplasia of the phalanges of the hand (HP:0009802) | 2.03863651 |
| 75 | Aplasia involving bones of the extremities (HP:0009825) | 2.03863651 |
| 76 | Stridor (HP:0010307) | 2.01752312 |
| 77 | Myocardial infarction (HP:0001658) | 1.99399527 |
| 78 | Abnormality of dentin (HP:0010299) | 1.97808495 |
| 79 | Mesangial abnormality (HP:0001966) | 1.94885225 |
| 80 | Metaphyseal cupping (HP:0003021) | 1.94738647 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 1.94533124 |
| 82 | Supranuclear gaze palsy (HP:0000605) | 1.94391081 |
| 83 | Aortic aneurysm (HP:0004942) | 1.93744750 |
| 84 | Generalized amyotrophy (HP:0003700) | 1.91459141 |
| 85 | Insomnia (HP:0100785) | 1.91254346 |
| 86 | Lower limb amyotrophy (HP:0007210) | 1.91018121 |
| 87 | Arterial tortuosity (HP:0005116) | 1.90190418 |
| 88 | Hyperacusis (HP:0010780) | 1.89761815 |
| 89 | Abnormality of the musculature of the hand (HP:0001421) | 1.89324083 |
| 90 | Lymphangioma (HP:0100764) | 1.87349867 |
| 91 | Disproportionate tall stature (HP:0001519) | 1.86421806 |
| 92 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84496491 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 1.84129457 |
| 94 | Hypertriglyceridemia (HP:0002155) | 1.83308496 |
| 95 | Plantar hyperkeratosis (HP:0007556) | 1.83206700 |
| 96 | Hyperextensible skin (HP:0000974) | 1.82471083 |
| 97 | Broad metatarsal (HP:0001783) | 1.81219609 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.80826175 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80287364 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.79915673 |
| 101 | Difficulty running (HP:0009046) | 1.79628358 |
| 102 | Type 1 muscle fiber predominance (HP:0003803) | 1.79596230 |
| 103 | Neuronal loss in central nervous system (HP:0002529) | 1.77250258 |
| 104 | Myopathic facies (HP:0002058) | 1.76226918 |
| 105 | Joint stiffness (HP:0001387) | 1.75981831 |
| 106 | Acanthosis nigricans (HP:0000956) | 1.75979361 |
| 107 | Bruising susceptibility (HP:0000978) | 1.75528776 |
| 108 | Increased CSF protein (HP:0002922) | 1.74583253 |
| 109 | Slender build (HP:0001533) | 1.73895586 |
| 110 | Spontaneous hematomas (HP:0007420) | 1.73619370 |
| 111 | Wormian bones (HP:0002645) | 1.72574977 |
| 112 | Focal segmental glomerulosclerosis (HP:0000097) | 1.72162574 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70355219 |
| 114 | Osteolytic defects of the hand bones (HP:0009699) | 1.70355219 |
| 115 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.70019848 |
| 116 | Loss of speech (HP:0002371) | 1.70000872 |
| 117 | Rapidly progressive (HP:0003678) | 1.68272652 |
| 118 | Peripheral hypomyelination (HP:0007182) | 1.67641737 |
| 119 | Spinal cord compression (HP:0002176) | 1.67480223 |
| 120 | Hyperthyroidism (HP:0000836) | 1.67213518 |
| 121 | Neonatal short-limb short stature (HP:0008921) | 1.65614166 |
| 122 | Buphthalmos (HP:0000557) | 1.64568441 |
| 123 | Fasciculations (HP:0002380) | 1.64197472 |
| 124 | Bulbar palsy (HP:0001283) | 1.63716333 |
| 125 | Bowel diverticulosis (HP:0005222) | 1.63654720 |
| 126 | Axonal loss (HP:0003447) | 1.63179587 |
| 127 | Deviation of the hallux (HP:0010051) | 1.62974408 |
| 128 | Action tremor (HP:0002345) | 1.62874860 |
| 129 | Follicular hyperkeratosis (HP:0007502) | 1.61587165 |
| 130 | Testicular neoplasm (HP:0010788) | 1.61488564 |
| 131 | Long toe (HP:0010511) | 1.60833139 |
| 132 | Gastrointestinal dysmotility (HP:0002579) | 1.60759744 |
| 133 | Thick nail (HP:0001805) | 1.58556824 |
| 134 | Thin ribs (HP:0000883) | 1.58298255 |
| 135 | Ulnar bowing (HP:0003031) | 1.58061728 |
| 136 | Biconcave vertebral bodies (HP:0004586) | 1.57838914 |
| 137 | Elbow flexion contracture (HP:0002987) | 1.57736964 |
| 138 | Easy fatigability (HP:0003388) | 1.57710563 |
| 139 | Gingival bleeding (HP:0000225) | 1.57409551 |
| 140 | Overgrowth (HP:0001548) | 1.57203346 |
| 141 | Back pain (HP:0003418) | 1.56908373 |
| 142 | Bone pain (HP:0002653) | 1.56667061 |
| 143 | Abnormal gallbladder physiology (HP:0012438) | 1.56433956 |
| 144 | Polygenic inheritance (HP:0010982) | 1.56281141 |
| 145 | Tetraparesis (HP:0002273) | 1.56081875 |
| 146 | Hallux valgus (HP:0001822) | 1.55703207 |
| 147 | Flat acetabular roof (HP:0003180) | 1.54698536 |
| 148 | Global brain atrophy (HP:0002283) | 1.53112348 |
| 149 | Muscle fibrillation (HP:0010546) | 1.52551330 |
| 150 | Stroke (HP:0001297) | 1.52295578 |
| 151 | Striae distensae (HP:0001065) | 1.51539008 |
| 152 | Vascular tortuosity (HP:0004948) | 1.51406693 |
| 153 | Venous abnormality (HP:0002624) | 1.51376769 |
| 154 | Palmoplantar hyperkeratosis (HP:0000972) | 1.51371468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.46947500 |
| 2 | RIPK1 | 3.03492041 |
| 3 | PRKD3 | 3.03096870 |
| 4 | PRPF4B | 2.73284363 |
| 5 | IRAK3 | 2.44296744 |
| 6 | LATS2 | 2.32871182 |
| 7 | ICK | 2.27639971 |
| 8 | ERN1 | 2.21570931 |
| 9 | MAP3K9 | 2.19681869 |
| 10 | TYRO3 | 2.10764576 |
| 11 | PKN2 | 2.09717986 |
| 12 | BMX | 2.06099940 |
| 13 | DDR2 | 1.96082835 |
| 14 | TAOK2 | 1.91430505 |
| 15 | MAP3K2 | 1.88629520 |
| 16 | TESK1 | 1.88325403 |
| 17 | KSR2 | 1.87735850 |
| 18 | MAP2K3 | 1.77736314 |
| 19 | PDGFRA | 1.74638882 |
| 20 | TAOK1 | 1.72769670 |
| 21 | SMG1 | 1.70859220 |
| 22 | PTK2B | 1.70683901 |
| 23 | EPHA2 | 1.70374500 |
| 24 | PTK6 | 1.70012065 |
| 25 | DAPK2 | 1.61132822 |
| 26 | PTK2 | 1.59858267 |
| 27 | MAP2K2 | 1.56974420 |
| 28 | LMTK2 | 1.54881157 |
| 29 | TTN | 1.50442737 |
| 30 | NTRK1 | 1.49352821 |
| 31 | NME2 | 1.44382454 |
| 32 | FER | 1.43293929 |
| 33 | MST1R | 1.41571313 |
| 34 | PAK6 | 1.38209317 |
| 35 | MYLK | 1.37773392 |
| 36 | CDK12 | 1.36171133 |
| 37 | EPHB2 | 1.35713058 |
| 38 | MAP3K6 | 1.35501378 |
| 39 | ARAF | 1.30975268 |
| 40 | MAP3K3 | 1.30288117 |
| 41 | EEF2K | 1.21971603 |
| 42 | MAP2K1 | 1.18326537 |
| 43 | NTRK3 | 1.14878180 |
| 44 | MAPKAPK3 | 1.12820400 |
| 45 | MAP3K11 | 1.12592948 |
| 46 | EPHB1 | 1.11530650 |
| 47 | MARK2 | 1.10631329 |
| 48 | MET | 1.09494110 |
| 49 | PAK2 | 1.07917386 |
| 50 | DMPK | 1.07340058 |
| 51 | STK38 | 1.06015413 |
| 52 | EPHA4 | 1.02587318 |
| 53 | CAMKK1 | 1.02217848 |
| 54 | LATS1 | 1.01795680 |
| 55 | RET | 1.01655740 |
| 56 | RPS6KA2 | 1.01324170 |
| 57 | WNK1 | 1.01250935 |
| 58 | PAK3 | 1.00705596 |
| 59 | TNK2 | 0.93808941 |
| 60 | PAK4 | 0.93794448 |
| 61 | MAP3K10 | 0.91479241 |
| 62 | MOS | 0.90865260 |
| 63 | MTOR | 0.89266574 |
| 64 | PDPK1 | 0.89171872 |
| 65 | MAP3K1 | 0.88273354 |
| 66 | TESK2 | 0.85961968 |
| 67 | MAP3K13 | 0.85912527 |
| 68 | DAPK3 | 0.83162100 |
| 69 | LIMK1 | 0.82204579 |
| 70 | ZAP70 | 0.80276338 |
| 71 | MINK1 | 0.78125805 |
| 72 | SIK1 | 0.77165633 |
| 73 | PDK2 | 0.76775335 |
| 74 | IRAK2 | 0.76709135 |
| 75 | CDC42BPA | 0.76328176 |
| 76 | MAPK15 | 0.74411703 |
| 77 | ALK | 0.74287866 |
| 78 | PIM2 | 0.74109139 |
| 79 | DYRK1B | 0.73263755 |
| 80 | SCYL2 | 0.72091694 |
| 81 | GRK5 | 0.71720441 |
| 82 | BRAF | 0.71218995 |
| 83 | CAMK1G | 0.69975646 |
| 84 | PDK3 | 0.68445333 |
| 85 | PDK4 | 0.68445333 |
| 86 | ILK | 0.67931359 |
| 87 | MAPK12 | 0.66731206 |
| 88 | PRKD2 | 0.66207881 |
| 89 | STK11 | 0.64473097 |
| 90 | ROCK1 | 0.62401987 |
| 91 | CAMK2G | 0.60668656 |
| 92 | CAMK1D | 0.58764215 |
| 93 | ROCK2 | 0.57218320 |
| 94 | LRRK2 | 0.57068366 |
| 95 | SIK3 | 0.56880004 |
| 96 | RIPK4 | 0.53076251 |
| 97 | PRKG2 | 0.52747993 |
| 98 | MAP2K4 | 0.51909307 |
| 99 | FGR | 0.51476960 |
| 100 | RPS6KC1 | 0.50316380 |
| 101 | RPS6KL1 | 0.50316380 |
| 102 | TBK1 | 0.50088434 |
| 103 | MAP3K7 | 0.49917136 |
| 104 | HIPK2 | 0.48726966 |
| 105 | WNK4 | 0.48532435 |
| 106 | CAMK2B | 0.46132431 |
| 107 | KDR | 0.45489295 |
| 108 | MAP3K8 | 0.44997825 |
| 109 | SIK2 | 0.44452534 |
| 110 | PAK1 | 0.44381626 |
| 111 | FGFR1 | 0.44224063 |
| 112 | PRKCH | 0.44166371 |
| 113 | EIF2AK1 | 0.43238705 |
| 114 | PDGFRB | 0.42317547 |
| 115 | PDK1 | 0.41289486 |
| 116 | DAPK1 | 0.40500405 |
| 117 | PRKD1 | 0.39666053 |
| 118 | CDK5 | 0.39423912 |
| 119 | GSK3A | 0.39177324 |
| 120 | MAP3K4 | 0.38920256 |
| 121 | SGK3 | 0.38893283 |
| 122 | ABL2 | 0.38715942 |
| 123 | TGFBR2 | 0.37381709 |
| 124 | RPS6KA1 | 0.36105137 |
| 125 | FGFR4 | 0.35712843 |
| 126 | CSK | 0.35663269 |
| 127 | STK3 | 0.34532780 |
| 128 | ERBB2 | 0.34415853 |
| 129 | GRK6 | 0.33286030 |
| 130 | PHKG2 | 0.32368356 |
| 131 | CDK14 | 0.31820844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.04435227 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.97669635 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95969525 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86977519 |
| 5 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.81080471 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.72896465 |
| 7 | Amoebiasis_Homo sapiens_hsa05146 | 1.65793893 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62613043 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.59218398 |
| 10 | Platelet activation_Homo sapiens_hsa04611 | 1.55928226 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.53069898 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52186942 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.45803979 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40768135 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38727305 |
| 16 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.34877042 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29132119 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28208696 |
| 19 | Glioma_Homo sapiens_hsa05214 | 1.25553326 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25162514 |
| 21 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22824868 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.22360490 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21420026 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.20880999 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.20432694 |
| 26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.19108055 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17987773 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.17104700 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17061518 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16446141 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16308868 |
| 32 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15504155 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14247461 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.14143010 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13751449 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 1.09581093 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06937841 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05544875 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03489873 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02432063 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.01833221 |
| 42 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01477466 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.01294979 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.99567029 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 0.98911589 |
| 46 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97448641 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97012205 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96137559 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95611574 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.94555922 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94370113 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.94089052 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93721874 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93603673 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93399629 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92407576 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90955763 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89960750 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89895281 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89826827 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88874298 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88698621 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87817526 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87622297 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87092505 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86635291 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85867229 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83921027 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82007600 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.81902221 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81682515 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81436390 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80908997 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80698602 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79629002 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79501406 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.79445785 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79064254 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78933493 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78763210 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78290785 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77151915 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76946013 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76918036 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76579280 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76154878 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.75371836 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74835386 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.74706789 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74440078 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73712624 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.72515970 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71511350 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71507703 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71017566 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69902902 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69734022 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.69617557 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69474342 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.68675208 |
| 101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68581702 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.68079577 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67341638 |
| 104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66468790 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65355789 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64938262 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64728239 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64462370 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64444715 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.63938180 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63729392 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62985375 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62843027 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62038888 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60957765 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60278570 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59080749 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.58914071 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57637050 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57469224 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57250265 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56673525 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56419644 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56037694 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55625814 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55028612 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54633629 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54546158 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53690195 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53414399 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | 0.52776247 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51351010 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51060328 |
| 134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50546192 |

